AdMeTech Hails New Research That Shows Promise Of MRI To Discriminate Aggressive Prostate Cancer From Dormant Disease

Posted by Jeff Daas on Mar 13th, 2010 | no comments

New preliminary data from a pilot study in the Netherlands indicates that imaging tools may help address the most challenging clinical dilemma of prostate cancer care as identified by the hearing of the House Oversight and Government Reform Committee and its expert witnesses last week: to treat or not treat, AdMeTech Foundation’s President and CEO Dr. Faina Shtern said today…
Read Full Article